z-logo
open-access-imgOpen Access
Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma
Author(s) -
Hironori Shigeoka,
Haruhiko Imamoto,
Yasumasa Nishimura,
Taro Shimono,
Hiroshi Furukawa,
Hiroshi Imamura,
Takushi Yasuda,
Hitoshi Shiozaki
Publication year - 2010
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v2.i6.282
Subject(s) - medicine , paraaortic lymph nodes , lymph node , chemoradiotherapy , gastrectomy , radiology , dissection (medical) , lymph , adenocarcinoma , cancer , radiation therapy , surgery , metastasis , pathology
This report presents a case of highly advanced gastric cancer that achieved a histologically complete response (CR) to preoperative chemoradiotherapy with S-1 plus low-dose Cisplatin. A 60-year-old male patient underwent FDG positron emission tomography (PET) during a routine health examination. The patient was found to have swollen paraaortic lymph nodes. Shortly thereafter, he was diagnosed with gastric carcinoma with a type 2 tumor in the antrum with paraaortic lymph node metastases based on FDG-PET, endoscopic examination and abdominal computed tomography. After the completion of chemoradiation therapy (CRT), the tumor and the paraaortic lymph node metastases disappeared. The patient underwent surgery 5 wk after the completion of CRT, including a subtotal gastrectomy with Roux-en-Y reconstruction, D3 lymph node dissection and a left adrenalectomy. No cancer cells were detected in the resected specimen either in the primary lesion or lymph nodes, thus confirming a pathologically CR to CRT (CR grade 3). The patient has been stable and well without any evidence of recurrence for 48 mo after surgery. Such a preoperative CRT regimen might therefore be very effective for treatment of some advanced gastric cancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here